Breast skin ulceration in de novo metastatic breast cancer: incidence, predictors, and patterns of occurrence
Celian Guyon(Institut Curie), Thomas Gaillard(Institut Curie), Enora Laas(Institut Curie), Jonathan Sabah(Institut Curie), Pierre Loap(Institut Curie), Claire Bonneau(Inserm), Luc Cabel(Université de Versailles Saint-Quentin-en-Yvelines), Louna Mossino Diaz(Institut Curie), Fabien Guffroy(Institut Curie), Toulsie Ramtohul(Université Paris Sciences et Lettres), Helene Didelot(Institut Curie), Jean‐Yves Pierga(Université Paris Cité)
Cited by 0
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
|Cancer Cell|2018|1.7k